Controlling Microbial Growth in the Body: Antimicrobial Drugs

Controlling Microbial Growth in the Body: Antimicrobial Drugs

The History of Antimicrobial Agents

Antimicrobial drugs are chemicals used to treat infectious diseases by inhibiting or killing microorganisms. The development of these agents revolutionized medicine, beginning with Paul Ehrlich's discovery of selective toxicity and Alexander Fleming's discovery of penicillin.

• Selective toxicity: The ability of a drug to target pathogens without harming the host.

• Antibiotics: Antimicrobial agents produced naturally by microorganisms.

• Synthetic drugs: Antimicrobial agents synthesized in laboratories.

• Example: Penicillin, the first widely used antibiotic, discovered by Alexander Fleming.

Mechanisms of Antimicrobial Action

Overview

Antimicrobial drugs act by targeting essential structures or functions in pathogens. The major mechanisms include inhibition of cell wall synthesis, protein synthesis, cytoplasmic membrane integrity, metabolic pathways, nucleic acid synthesis, and prevention of viral attachment or entry.

• Inhibition of cell wall synthesis

• Inhibition of protein synthesis

• Disruption of cytoplasmic membranes

• Inhibition of metabolic pathways

• Inhibition of nucleic acid synthesis

• Prevention of virus attachment, entry, or uncoating

Inhibition of Cell Wall Synthesis

Drugs such as penicillins and cephalosporins prevent the synthesis of peptidoglycan, weakening bacterial cell walls and causing cell lysis. These drugs are most effective against actively growing bacteria.

• Peptidoglycan: A polymer that forms the bacterial cell wall.

• Example: Penicillin inhibits the cross-linking of peptidoglycan strands.

Inhibition of Protein Synthesis

Antimicrobial agents exploit differences between prokaryotic and eukaryotic ribosomes to selectively inhibit bacterial protein synthesis. Drugs may target the 30S or 50S ribosomal subunits, interfering with translation.

• Example: Tetracyclines bind to the 30S subunit, blocking tRNA attachment.

• Example: Chloramphenicol inhibits peptide bond formation at the 50S subunit.

Disruption of Cytoplasmic Membranes

Some drugs, such as polymyxins, disrupt the integrity of the cytoplasmic membrane, causing leakage of cellular contents and cell death. These are mainly used against Gram-negative bacteria.

• Example: Polymyxin B disrupts bacterial cell membranes.

Inhibition of Metabolic Pathways

Antimicrobial agents can inhibit key metabolic pathways unique to pathogens. Sulfonamides, for example, inhibit folic acid synthesis in bacteria.

• Example: Sulfonamides act as competitive inhibitors of enzymes in folic acid synthesis.

Inhibition of Nucleic Acid Synthesis

Drugs may block the replication or transcription of DNA and RNA, preventing cell division and protein synthesis. These drugs are often used against viruses and rapidly dividing cells.

• Example: Rifampin inhibits bacterial RNA polymerase.

• Example: Quinolones inhibit DNA gyrase, preventing DNA replication.

Prevention of Virus Attachment, Entry, or Uncoating

Some antiviral drugs block the attachment of viruses to host cells or prevent the uncoating process necessary for viral replication.

• Example: Amantadine prevents influenza virus uncoating.

Clinical Considerations in Prescribing Antimicrobial Drugs

Spectrum of Action

Antimicrobial drugs may have a broad or narrow spectrum of activity, affecting a wide range of pathogens or targeting specific groups.

• Broad-spectrum drugs: Effective against many types of bacteria.

• Narrow-spectrum drugs: Target specific bacteria, reducing impact on normal microbiota.

Effectiveness

The effectiveness of antimicrobial drugs is measured by their ability to inhibit or kill pathogens. Laboratory tests such as the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) are used to determine potency.

• Minimum inhibitory concentration (MIC): The lowest concentration of a drug that prevents visible growth of a microorganism.

• Minimum bactericidal concentration (MBC): The lowest concentration of a drug that kills the microorganism.

• Equation: $\text{MIC} = \min \{C : \text{no visible growth} \}$

Routes of Administration

Drugs can be administered orally, intravenously, intramuscularly, or topically. The route affects drug absorption, distribution, and effectiveness.

• Oral administration: Convenient but may result in lower drug concentrations.

• Intravenous administration: Provides rapid and high drug levels.

Safety and Side Effects

Antimicrobial drugs may cause toxicity, allergic reactions, or disruption of normal microbiota.

• Toxicity: Damage to organs such as liver, kidneys, or nerves.

• Allergies: Immune reactions ranging from mild to severe.

• Disruption of normal microbiota: May lead to secondary infections (e.g., yeast infections).

Resistance to Antimicrobial Drugs

The Development of Resistance in Populations

Microbial populations can develop resistance through genetic mutations or acquisition of resistance genes. Resistant cells survive drug exposure and proliferate.

• Antimicrobial resistance: The ability of microbes to withstand the effects of drugs.

• Example: Methicillin-resistant Staphylococcus aureus (MRSA).

Mechanisms of Resistance

• Production of enzymes that destroy or inactivate drugs (e.g., beta-lactamases).

• Alteration of drug targets (e.g., changes in ribosomal proteins).

• Changes in membrane permeability to prevent drug entry.

• Efflux pumps that remove drugs from the cell.

Multiple Resistance and Cross Resistance

Microbes may develop resistance to multiple drugs, especially when exposed to several agents simultaneously. Cross resistance occurs when resistance to one drug confers resistance to similar drugs.

• Example: Resistance to both penicillins and cephalosporins due to beta-lactamase production.

Retarding Resistance

Strategies to slow the development of resistance include using drugs only when necessary, combining drugs, and developing new agents.

• Use antimicrobials only when needed.

• Combine drugs to reduce resistance development.

• Develop new drugs and modify existing ones.

Mechanism	Example	Target
Inhibition of cell wall synthesis	Penicillin	Peptidoglycan
Inhibition of protein synthesis	Tetracycline	30S ribosomal subunit
Disruption of cytoplasmic membrane	Polymyxin B	Cell membrane
Inhibition of metabolic pathways	Sulfonamides	Folic acid synthesis
Inhibition of nucleic acid synthesis	Rifampin	RNA polymerase
Prevention of virus attachment/entry	Amantadine	Viral uncoating

Additional info: The notes have been expanded with definitions, examples, and a summary table for mechanisms of antimicrobial action to provide a comprehensive study guide for exam preparation.